Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2009

Open Access 01-12-2009 | Original investigation

Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)

Authors: Ville-Petteri Mäkinen, Carol Forsblom, Lena M Thorn, Johan Wadén, Kimmo Kaski, Mika Ala-Korpela, Per-Henrik Groop

Published in: Cardiovascular Diabetology | Issue 1/2009

Login to get access

Abstract

Background

Cardiovascular disease is the main cause of premature death in patients with type 1 diabetes. Patients with diabetic kidney disease have an increased risk of heart attack or stroke. Accurate knowledge of the complex inter-dependencies between the risk factors is critical for pinpointing the best targets for research and treatment. Therefore, the aim of this study was to describe the association patterns between clinical and biochemical features of diabetic complications.

Methods

Medical records and serum and urine samples of 4,197 patients with type 1 diabetes were collected from health care centers in Finland. At baseline, the mean diabetes duration was 22 years, 52% were male, 23% had kidney disease (urine albumin excretion over 300 mg/24 h or end-stage renal disease) and 8% had a history of macrovascular events. All-cause mortality was evaluated after an average of 6.5 years of follow-up (25,714 patient years). The dataset comprised 28 clinical and 25 biochemical variables that were regarded as the nodes of a network to assess their mutual relationships.

Results

The networks contained cliques that were densely inter-connected (r > 0.6), including cliques for high-density lipoprotein (HDL) markers, for triglycerides and cholesterol, for urinary excretion and for indices of body mass. The links between the cliques showed biologically relevant interactions: an inverse relationship between HDL cholesterol and the triglyceride clique (r < -0.3, P < 10-16), a connection between triglycerides and body mass via C-reactive protein (r > 0.3, P < 10-16) and intermediate-density cholesterol as the connector between lipoprotein metabolism and albuminuria (r > 0.3, P < 10-16). Aging and macrovascular disease were linked to death via working ability and retinopathy. Diabetic kidney disease, serum creatinine and potassium, retinopathy and blood pressure were inter-connected. Blood pressure correlations indicated accelerated vascular aging in individuals with kidney disease (P < 0.001).

Conclusion

The complex pattern of links between diverse characteristics and the lack of a single dominant factor suggests a need for multifactorial and multidisciplinary paradigms for the research, treatment and prevention of diabetic complications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C: Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA. 2005, 294: 1782-1787. 10.1001/jama.294.14.1782.CrossRefPubMed Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C: Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA. 2005, 294: 1782-1787. 10.1001/jama.294.14.1782.CrossRefPubMed
2.
go back to reference Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005, 28: 164-176. 10.2337/diacare.28.1.164.CrossRefPubMed Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005, 28: 164-176. 10.2337/diacare.28.1.164.CrossRefPubMed
3.
go back to reference Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001, 44 (Suppl 2): S14-21. 10.1007/PL00002934.CrossRefPubMed Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H: Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001, 44 (Suppl 2): S14-21. 10.1007/PL00002934.CrossRefPubMed
4.
go back to reference Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving H: Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation. 2007, 115: 228-235. 10.1161/CIRCULATIONAHA.106.633339.CrossRefPubMed Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving H: Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation. 2007, 115: 228-235. 10.1161/CIRCULATIONAHA.106.633339.CrossRefPubMed
5.
go back to reference Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G: Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008, 31: 2006-2012. 10.2337/dc08-0659.PubMedCentralCrossRefPubMed Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G: Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008, 31: 2006-2012. 10.2337/dc08-0659.PubMedCentralCrossRefPubMed
6.
go back to reference Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH: Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008, 31: 1360-1366. 10.2337/dc08-0107.PubMedCentralCrossRefPubMed Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH: Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008, 31: 1360-1366. 10.2337/dc08-0107.PubMedCentralCrossRefPubMed
7.
go back to reference Thorn LM, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Kilpikari R, Groop PH: Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care. 2007, 30: 1162-1167. 10.2337/dc06-2033.CrossRefPubMed Thorn LM, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Kilpikari R, Groop PH: Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care. 2007, 30: 1162-1167. 10.2337/dc06-2033.CrossRefPubMed
8.
go back to reference Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia. 2000, 43: 148-155. 10.1007/s001250050023.CrossRefPubMed Lehto S, Rönnemaa T, Pyörälä K, Laakso M: Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia. 2000, 43: 148-155. 10.1007/s001250050023.CrossRefPubMed
9.
go back to reference Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D: Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2008, 7: 89-95. 10.1089/met.2008.0046.CrossRef Mayer-Davis EJ, Ma B, Lawson A, D'Agostino RB, Liese AD, Bell RA, Dabelea D, Dolan L, Pettitt DJ, Rodriguez BL, Williams D: Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2008, 7: 89-95. 10.1089/met.2008.0046.CrossRef
10.
go back to reference Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008, 358: 2107-2116. 10.1056/NEJMoa0707064.CrossRefPubMed Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlöv J: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008, 358: 2107-2116. 10.1056/NEJMoa0707064.CrossRefPubMed
11.
go back to reference Barabasi A, Albert R: Emergence of scaling in random networks. Science. 1999, 286: 509-512. 10.1126/science.286.5439.509.CrossRefPubMed Barabasi A, Albert R: Emergence of scaling in random networks. Science. 1999, 286: 509-512. 10.1126/science.286.5439.509.CrossRefPubMed
12.
go back to reference Pawson T, Linding R: Network medicine. FEBS Lett. 2008, 582: 1266-1270. 10.1016/j.febslet.2008.02.011.CrossRefPubMed Pawson T, Linding R: Network medicine. FEBS Lett. 2008, 582: 1266-1270. 10.1016/j.febslet.2008.02.011.CrossRefPubMed
13.
go back to reference Onnela J, Saramäki J, Hyvönen J, Szabó G, Lazer D, Kaski K, Kertész J, Barabási A: Structure and tie strengths in mobile communication networks. Proc Natl Acad Sci USA. 2007, 104: 7332-7336. 10.1073/pnas.0610245104.PubMedCentralCrossRefPubMed Onnela J, Saramäki J, Hyvönen J, Szabó G, Lazer D, Kaski K, Kertész J, Barabási A: Structure and tie strengths in mobile communication networks. Proc Natl Acad Sci USA. 2007, 104: 7332-7336. 10.1073/pnas.0610245104.PubMedCentralCrossRefPubMed
14.
go back to reference Palla G, Barabási A, Vicsek T: Quantifying social group evolution. Nature. 2007, 446: 664-667. 10.1038/nature05670.CrossRefPubMed Palla G, Barabási A, Vicsek T: Quantifying social group evolution. Nature. 2007, 446: 664-667. 10.1038/nature05670.CrossRefPubMed
15.
go back to reference Pieroni E, de la Fuente van Bentem S, Mancosu G, Capobianco E, Hirt H, de la Fuente A: Protein networking: insights into global functional organization of proteomes. Proteomics. 2008, 8: 799-816. 10.1002/pmic.200700767.CrossRefPubMed Pieroni E, de la Fuente van Bentem S, Mancosu G, Capobianco E, Hirt H, de la Fuente A: Protein networking: insights into global functional organization of proteomes. Proteomics. 2008, 8: 799-816. 10.1002/pmic.200700767.CrossRefPubMed
16.
go back to reference Lee D, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabási A: The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA. 2008, 105: 9880-9885. 10.1073/pnas.0802208105.PubMedCentralCrossRefPubMed Lee D, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabási A: The implications of human metabolic network topology for disease comorbidity. Proc Natl Acad Sci USA. 2008, 105: 9880-9885. 10.1073/pnas.0802208105.PubMedCentralCrossRefPubMed
17.
go back to reference Saramäki J, Kaski K: Modelling development of epidemics with dynamic small-world networks. J Theor Biol. 2005, 234: 413-421. 10.1016/j.jtbi.2004.12.003.CrossRefPubMed Saramäki J, Kaski K: Modelling development of epidemics with dynamic small-world networks. J Theor Biol. 2005, 234: 413-421. 10.1016/j.jtbi.2004.12.003.CrossRefPubMed
18.
19.
go back to reference Nils Weskamp N, Hullermeier E, Klebe G: Merging chemical and biological space: structural mapping of enzyme binding pocket space. Proteins. 2009, 76: 317-330. 10.1002/prot.22345.CrossRefPubMed Nils Weskamp N, Hullermeier E, Klebe G: Merging chemical and biological space: structural mapping of enzyme binding pocket space. Proteins. 2009, 76: 317-330. 10.1002/prot.22345.CrossRefPubMed
20.
go back to reference Bhattacharya K, Mukherjee G, Saramäki J, Kaski K, Manna S: The international trade network: weighted network analysis and modelling. J Stat Mech. 2008, P02002-10.1088/1742-5468/2008/02/P02002. Bhattacharya K, Mukherjee G, Saramäki J, Kaski K, Manna S: The international trade network: weighted network analysis and modelling. J Stat Mech. 2008, P02002-10.1088/1742-5468/2008/02/P02002.
21.
go back to reference Niemi J, Mäkinen VP, Heikkonen J, Tenkanen L, Hiltunen Y, Hannuksela M, Jauhiainen M, Forsblom C, Taskinen M, Kesäniemi Y, Savolainen M, Kaski K, Groop PH, Kovanen P, Ala-Korpela M: Estimation of VLDL, IDL, LDL, HDL2, apoA-I and apoB from the Friedewald inputs - apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med. 2009, 1-11. Niemi J, Mäkinen VP, Heikkonen J, Tenkanen L, Hiltunen Y, Hannuksela M, Jauhiainen M, Forsblom C, Taskinen M, Kesäniemi Y, Savolainen M, Kaski K, Groop PH, Kovanen P, Ala-Korpela M: Estimation of VLDL, IDL, LDL, HDL2, apoA-I and apoB from the Friedewald inputs - apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes. Ann Med. 2009, 1-11.
22.
go back to reference Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH: Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes. 2008, 57: 2480-2487. 10.2337/db08-0332.PubMedCentralCrossRefPubMed Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH: Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes. 2008, 57: 2480-2487. 10.2337/db08-0332.PubMedCentralCrossRefPubMed
23.
go back to reference Tumminello M, Aste T, Di Matteo T, Mantegna RN: A tool for filtering information in complex systems. Proc Natl Acad Sci USA. 2005, 102: 10421-10426. 10.1073/pnas.0500298102.PubMedCentralCrossRefPubMed Tumminello M, Aste T, Di Matteo T, Mantegna RN: A tool for filtering information in complex systems. Proc Natl Acad Sci USA. 2005, 102: 10421-10426. 10.1073/pnas.0500298102.PubMedCentralCrossRefPubMed
24.
go back to reference Onnela J, Chakraborti A, Kaski K, Kertesz J: Dynamic asset trees and black monday. Physica A. 2003, 324: 227-252. 10.1016/S0378-4371(02)01882-4.CrossRef Onnela J, Chakraborti A, Kaski K, Kertesz J: Dynamic asset trees and black monday. Physica A. 2003, 324: 227-252. 10.1016/S0378-4371(02)01882-4.CrossRef
25.
go back to reference Davidson MH, Toth PP: High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol. 2007, 100: 32-40. 10.1016/j.amjcard.2007.08.011.CrossRef Davidson MH, Toth PP: High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardiol. 2007, 100: 32-40. 10.1016/j.amjcard.2007.08.011.CrossRef
26.
go back to reference The Diabetes Control and Complications Trial: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056/NEJM199309303291401.CrossRef The Diabetes Control and Complications Trial: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056/NEJM199309303291401.CrossRef
27.
go back to reference The Diabetes Control and Complications Trial and Follow-up Study: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000, 342: 381-386. 10.1056/NEJM200002103420603.CrossRef The Diabetes Control and Complications Trial and Follow-up Study: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000, 342: 381-386. 10.1056/NEJM200002103420603.CrossRef
28.
go back to reference Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH: A1c variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. DOI:10.2337/db09-0693 Wadén J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop PH: A1c variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. DOI:10.2337/db09-0693
29.
go back to reference Brownlee M: The pathological implications of protein glycation. Clin Invest Med. 1995, 18: 275-281.PubMed Brownlee M: The pathological implications of protein glycation. Clin Invest Med. 1995, 18: 275-281.PubMed
30.
go back to reference Lindholm E, Hallengren B, Agardh C: Gender differences in gad antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev. 2004, 20: 158-164. 10.1002/dmrr.420.CrossRefPubMed Lindholm E, Hallengren B, Agardh C: Gender differences in gad antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev. 2004, 20: 158-164. 10.1002/dmrr.420.CrossRefPubMed
31.
go back to reference Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop P, Ala-Korpela M: 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol. 2008, 4: 167-10.1038/msb4100205.PubMedCentralCrossRefPubMed Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop P, Ala-Korpela M: 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol. 2008, 4: 167-10.1038/msb4100205.PubMedCentralCrossRefPubMed
32.
go back to reference Chaturvedi N, Fuller JH, Taskinen MR: Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care. 2001, 24: 2071-2077. 10.2337/diacare.24.12.2071.CrossRefPubMed Chaturvedi N, Fuller JH, Taskinen MR: Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care. 2001, 24: 2071-2077. 10.2337/diacare.24.12.2071.CrossRefPubMed
33.
go back to reference Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR: Multiple lipoprotein abnormalities in type i diabetic patients with renal disease. Diabetes. 1996, 45: 974-979. 10.2337/diabetes.45.7.974.CrossRefPubMed Groop PH, Elliott T, Ekstrand A, Franssila-Kallunki A, Friedman R, Viberti GC, Taskinen MR: Multiple lipoprotein abnormalities in type i diabetic patients with renal disease. Diabetes. 1996, 45: 974-979. 10.2337/diabetes.45.7.974.CrossRefPubMed
34.
go back to reference Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Taskinen M, Viberti G: HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007, 30: 2706-2707. 10.2337/dc07-0030.CrossRefPubMed Groop PH, Thomas MC, Rosengård-Bärlund M, Mills V, Rönnback M, Thomas S, Forsblom C, Taskinen M, Viberti G: HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes. Diabetes Care. 2007, 30: 2706-2707. 10.2337/dc07-0030.CrossRefPubMed
35.
go back to reference Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H: Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol. 2005, 25: 2615-2622. 10.1161/01.ATV.0000188555.60475.c2.CrossRefPubMed Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H: Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol. 2005, 25: 2615-2622. 10.1161/01.ATV.0000188555.60475.c2.CrossRefPubMed
36.
go back to reference Yang X, Ma RC, So W, Ko GT, Kong AP, Lam CW, Ho C, Cockram CS, Wong VC, Tong PC, Chan JC: Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong Diabetes Registry. Cardiovasc Diabetol. 2007, 6: 37-10.1186/1475-2840-6-37.PubMedCentralCrossRefPubMed Yang X, Ma RC, So W, Ko GT, Kong AP, Lam CW, Ho C, Cockram CS, Wong VC, Tong PC, Chan JC: Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong Diabetes Registry. Cardiovasc Diabetol. 2007, 6: 37-10.1186/1475-2840-6-37.PubMedCentralCrossRefPubMed
37.
go back to reference Steinberg GR: Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle. 2007, 6: 888-894.CrossRefPubMed Steinberg GR: Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle. 2007, 6: 888-894.CrossRefPubMed
38.
go back to reference Goldfine AB, Kahn CR: Adiponectin: linking the fat cell to insulin sensitivity. Lancet. 2003, 362: 1431-1432. 10.1016/S0140-6736(03)14727-7.CrossRefPubMed Goldfine AB, Kahn CR: Adiponectin: linking the fat cell to insulin sensitivity. Lancet. 2003, 362: 1431-1432. 10.1016/S0140-6736(03)14727-7.CrossRefPubMed
39.
go back to reference Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003, 46: 459-469.PubMed Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003, 46: 459-469.PubMed
40.
go back to reference Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop P: Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2008, 31: 1165-1169. 10.2337/dc07-2306.CrossRefPubMed Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop P: Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2008, 31: 1165-1169. 10.2337/dc07-2306.CrossRefPubMed
41.
go back to reference Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L: Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004, 65: 274-281. 10.1111/j.1523-1755.2004.00370.x.CrossRefPubMed Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L: Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004, 65: 274-281. 10.1111/j.1523-1755.2004.00370.x.CrossRefPubMed
42.
go back to reference Groop PH, Forsblom C, Thomas MC: Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab. 2005, 1: 100-110. 10.1038/ncpendmet0046.CrossRefPubMed Groop PH, Forsblom C, Thomas MC: Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nat Clin Pract Endocrinol Metab. 2005, 1: 100-110. 10.1038/ncpendmet0046.CrossRefPubMed
43.
go back to reference Giannattasio C, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F, Mancia G: Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia. 1999, 42: 987-994. 10.1007/s001250051257.CrossRefPubMed Giannattasio C, Failla M, Piperno A, Grappiolo A, Gamba P, Paleari F, Mancia G: Early impairment of large artery structure and function in type I diabetes mellitus. Diabetologia. 1999, 42: 987-994. 10.1007/s001250051257.CrossRefPubMed
44.
go back to reference Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH: Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004, 110: 1076-1082. 10.1161/01.CIR.0000139903.29522.8D.CrossRefPubMed Rönnback M, Fagerudd J, Forsblom C, Pettersson-Fernholm K, Reunanen A, Groop PH: Altered age-related blood pressure pattern in type 1 diabetes. Circulation. 2004, 110: 1076-1082. 10.1161/01.CIR.0000139903.29522.8D.CrossRefPubMed
45.
go back to reference Thomas MC, Atkins RC: Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs. 2006, 66: 2213-2234. 10.2165/00003495-200666170-00005.CrossRefPubMed Thomas MC, Atkins RC: Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs. 2006, 66: 2213-2234. 10.2165/00003495-200666170-00005.CrossRefPubMed
46.
go back to reference La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int. 2001, 60: 1964-1971. 10.1046/j.1523-1755.2001.00008.x.CrossRefPubMed La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int. 2001, 60: 1964-1971. 10.1046/j.1523-1755.2001.00008.x.CrossRefPubMed
Metadata
Title
Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)
Authors
Ville-Petteri Mäkinen
Carol Forsblom
Lena M Thorn
Johan Wadén
Kimmo Kaski
Mika Ala-Korpela
Per-Henrik Groop
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2009
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-8-54

Other articles of this Issue 1/2009

Cardiovascular Diabetology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.